KoBioLabs, Inc (KOSDAQ:348150)

KoBioLabs Revenue

KoBioLabs had revenue of 21.81B KRW in the quarter ending June 30, 2026, with 23.83% growth. This brings the company's total for the last twelve months to 75.41B, up 8.54% year-over-year. In the year 2025, KoBioLabs had annual revenue of 69.29B with 1.36% growth. That makes KoBioLabs the 27,191st largest company in the world by revenue and 1,632nd in South Korea.

• Revenue (ttm): 75.41B
• Revenue Growth: +8.54%
• P/S Ratio: 0.67
• Revenue / Employee: 1.48B
• Employees: 51
• Market Cap: 50.78B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South Korea 69.20B 99.9%
• Overseas 92.29M 0.1%

Fiscal year ended Dec 31, 2025 See the full KoBioLabs breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	69.29B	932.96M	1.36%
Dec 31, 2024	68.36B	35.22B	106.28%
Dec 31, 2023	33.14B	21.53B	185.54%
Dec 31, 2022	11.61B	8.71B	301.12%
Dec 31, 2021	2.89B	-1.70B	-36.98%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error